XTL BIOPHARMACEUTICALS LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.5 ILa | -2.30% |
|
-7.61% | +142.86% |
| 05/06 | XTL Biopharmaceuticals Signs Deal to Acquire The Social Proxy | MT |
| 05/06 | XTL Biopharmaceuticals Ltd. announced that it has received $1.5 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.24Cr | - | - | - | - | - | |
| 5.69TCr | - | |||||
| 4.03TCr | ||||||
| 3.93TCr | ||||||
| 2.84TCr | ||||||
| 2.64TCr |
